Growth Metrics

Mannkind (MNKD) Non-Current Deffered Revenue (2017 - 2026)

Mannkind (MNKD) reported Non-Current Deffered Revenue of $38.9 million for Q1 2026, down 17.85% year-over-year from $47.4 million in Q1 2025, and down 2.68% on a QoQ basis from $40.0 million in Q4 2025.

Mannkind (MNKD) has 10 years of Non-Current Deffered Revenue data on file, last reported at $38.9 million in Q1 2026.

  • Quarterly Non-Current Deffered Revenue fell 17.85% year-over-year to $38.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.9 million (down 17.85% YoY) and the FY2025 annual result came in at $40.0 million, down 21.86% from the prior year.
  • Non-Current Deffered Revenue declined to $38.9 million in Q1 2026 per MNKD's latest filing, from $40.0 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $69.8 million in Q4 2023 and bottomed at $1.2 million in Q1 2023.
  • The 5-year median for Non-Current Deffered Revenue is $47.4 million (2025), against an average of $46.8 million.
  • The widest annual swing landed in 2023, when Non-Current Deffered Revenue slumped 95.41%; it then surged 5545.08% in 2024.
  • Tracing MNKD's Non-Current Deffered Revenue over 5 years: stood at $37.7 million in 2022, then surged by 85.21% to $69.8 million in 2023, then decreased by 26.7% to $51.2 million in 2024, then dropped by 21.86% to $40.0 million in 2025, then decreased by 2.68% to $38.9 million in 2026.
  • Per Business Quant, the three latest MNKD Non-Current Deffered Revenue figures stand at $38.9 million (Q1 2026), $40.0 million (Q4 2025), and $48.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 225.10 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn 38.91 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 38.91 Mn
Dec 31, 2025 39.98 Mn
Sep 30, 2025 48.19 Mn
Jun 30, 2025 45.47 Mn
Mar 31, 2025 47.36 Mn
Dec 31, 2024 51.16 Mn
Sep 30, 2024 65.15 Mn
Jun 30, 2024 66.12 Mn
Mar 31, 2024 67.74 Mn
Dec 31, 2023 69.79 Mn
Sep 30, 2023 69.47 Mn
Jun 30, 2023 60.25 Mn
Mar 31, 2023 1.20 Mn
Dec 31, 2022 37.68 Mn
Sep 30, 2022 32.00 Mn
Jun 30, 2022 29.76 Mn
Mar 31, 2022 26.12 Mn
Dec 31, 2021 19.54 Mn
Sep 30, 2021 1.55 Mn
Jun 30, 2021 1.59 Mn
Mar 31, 2021 1.63 Mn
Dec 31, 2020 1.66 Mn
Sep 30, 2020 1.70 Mn
Jun 30, 2020 4.86 Mn
Mar 31, 2020 1.77 Mn
Dec 31, 2019 8.34 Mn
Sep 30, 2019 2.63 Mn
Jun 30, 2019 8.40 Mn
Mar 31, 2019 15.87 Mn
Dec 31, 2018 10.68 Mn
Dec 31, 2017 500,000.00